Showing results (751-760 of 3,103) with videos related to
Sort By:
Pageof 311
Drug Safety|August 28, 2026
Predictive Safety in the Era of Artificial Intelligence: Promises, Limits, and the Case for an Enterprise Lifecycle Evidence EcosystemTarek A Hammad, Justine Rochon, Kate Gofman, et al.Drug Safety|October 1, 2026
Drug Brand Switching: A Regulatory PerspectivePing Siu Kee, Paul K L Chin, Michael Tatley, et al.Drug Safety|October 8, 2026
Switching Patterns of Oral Retinoids to Alternative Medications: An Interrupted Time-Series Analysis of Four European CountriesJudit Riera-Arnau, Shahab Abtahi, Mònica Sabaté Gallego, et al.Drug Safety|October 14, 2026
Reassessing the Neoplasm Signal with Fezolinetant: Regulatory Inference, Mechanistic Plausibility, and the Case for Proactive PharmacovigilanceGlen Clack, Jennifer RenwickDrug Safety|October 22, 2026
EudraScore: Modification of the Vigi4Eudra-score for the Assessment of the Completeness of Adverse Drug Reaction Reports in EudraVigilanceDiana Dubrall, Patrick Christ, Dennis Lex, et al.Drug Safety|June 23, 2001
Tolerability of treatments for viral hepatitisA Gervais, N Boyer, P MarcellinDrug Safety|July 3, 2002
'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: is this a class effect?K Ray Chaudhuri, Suvankar Pal, Christine Brefel-CourbonDrug Safety|July 26, 2002
Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulideUrs A BoelsterliDrug Safety|July 26, 2002
Adverse effects of observational studies when examining adverse outcomes of drugs: case-control studies with low prevalence of exposurePeter C Austin, Muhammad Mamdani, Ivan J WilliamsDrug Safety|October 17, 2002
Oral contraception and the risk of thromboembolism: what does it mean to clinicians and their patients?James DrifePageof 311